ResMed Inc.
RMD · NYSE
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q4 | August 6, 2026 | — | 1.46B | — | 2.90 | — |
| 2026 Q3 | April 30, 2026 | 1.43B | 1.42B | 2.74 | 2.79 | -4.11% |
| 2026 Q2 | January 29, 2026 | 1.42B | 1.40B | 2.81 | 2.69 | +0.27% |
| 2026 Q1 | October 30, 2025 | 1.34B | 1.33B | 2.55 | 2.49 | -2.13% |
| 2025 Q4 | July 31, 2025 | 1.35B | 1.35B | 2.55 | 2.46 | +2.67% |
| 2025 Q3 | April 23, 2025 | 1.29B | 1.29B | 2.37 | 2.36 | +10.10% |
| 2025 Q2 | January 30, 2025 | 1.28B | 1.27B | 2.43 | 2.30 | -8.33% |
| 2025 Q1 | October 24, 2024 | 1.22B | 1.19B | 2.20 | 2.03 | +7.12% |
| 2024 Q4 | August 1, 2024 | 1.22B | 1.22B | 2.08 | 2.03 | +4.23% |
| 2024 Q3 | April 25, 2024 | 1.20B | 1.17B | 2.13 | 1.92 | +18.89% |
| 2024 Q2 | January 24, 2024 | 1.16B | 1.15B | 1.88 | 1.81 | +8.48% |
| 2024 Q1 | October 26, 2023 | 963.04M | 1.10B | 1.64 | 1.63 | -2.94% |
| 2023 Q4 | August 3, 2023 | 1.12B | 1.14B | 1.60 | 1.67 | -18.50% |
| 2023 Q3 | April 27, 2023 | 1.12B | 1.13B | 1.68 | 1.57 | +6.95% |
| 2023 Q2 | January 26, 2023 | 1.03B | 996.10M | 1.66 | 1.60 | -3.26% |
| 2023 Q1 | October 27, 2022 | 950.29M | 949.78M | 1.51 | 1.52 | -5.84% |